Planes de tratamiento individualizados para pacientes.

The Neuroscience Institute at Baylor Scott & White Medical Center - Templo offers the complete spectrum of diagnostics and treatment. With specialists from neurology, neurosurgery, neuro-oncology, neuropsychology and neurointerventional surgery, we offer advanced and individualized treatment plans for patients.

Tratamiento y servicios

Programa de tumores cerebrales y de columna

El Instituto de Neurociencia Baylor Scott & White ofrece atención experta a pacientes que luchan contra tumores del cerebro y la columna. En colaboración con el Baylor Scott & White Cancer Institute, el Programa de tumores cerebrales y de columna proporciona tratamiento avanzado para pacientes con tumores cerebrales y complicaciones neurológicas del cáncer.

Nuestro equipo del programa de tumores cerebrales y de columna de Temple incluye:

  • Neurologists
  • Neurocirujanos
  • Neurooncólogos
  • Oncólogos radioterapeutas
  • Oncólogos quirúrgicos
La mayoría de los pacientes con tumores cerebrales y de columna serán atendidos en el Baylor Scott & White Vasicek Cancer Treatment Center - Templo en el campus del Templo. Allí, se reúnen con un equipo de médicos para determinar las mejores opciones de tratamiento.

Logros

Baylor Scott & White Medical Center: los logros del Centro Integral de Accidentes Cerebrovasculares de Temple incluyen:

  • 2024 American Heart Association / American Stroke Association Get with The Guidelines Stroke Gold Plus designation, recognizing demonstrated performance for 24 or more consecutive months
  • 2024 recipient of Target Stroke Honor Roll Elite Award (American Heart Association / American Stroke Association) and Type 2 Diabetes Honor Roll Award
  • To earn this award, clot-busting (thrombolytic) medication must be delivered within 60 minutes to at least 85% of acute ischemic stroke patients.
  • In 2023, the median time for administering clot-busting medication was 39 minutes, with 96.7% of patients receiving it within 60 minutes of arriving in the emergency department and 86% of patients receiving it within 45 minutes
  • 97.8% compliance with all American Heart Association / American Stroke Association Stroke Measures in 2023
  • In 2023, 93 patients were treated with clot-busting medication, and 53 patients were treated with mechanical endovascular reperfusion therapy
  • 2023 demonstrated 4% serious complication rate for symptomatic patients that have had a carotid endarterectomy or carotid stenting procedure and 0% serious complication rate for asymptomatic patients that have had a carotid endarterectomy or carotid stenting procedure at Baylor Scott & White Medical Center – Temple. This rate is below the benchmark set forth by The Joint Commission
  • Serious complications can include stroke, death or Ataque al corazón after the procedure
  • Para minimizar el riesgo de accidente cerebrovascular, un proveedor puede recomendar que el paciente se someta a una endarterectomía carotídea o un procedimiento de colocación de stent carotídeo para restaurar el flujo sanguíneo en la arteria del cuello y al cerebro.